Green tea helps in rheumatoid arthritis
Rheumatoid arthritis is an autoimmune disease refers to: immune system mistakenly attacks cells begin own tissue or extracellular matrix. This results in inflammation, it can develop tissue fibrosis and other complications. In rheumatoid arthritis primarily occurs joint disease. In Russia, the disease affects about one million people. Thus women it occurs several times more often than men.
"Existing treatments for rheumatoid arthritis road inhibit operation of the entire immune system and are often unsuitable for long-term use," - said the head of research Sallahuddin Ahmed (Salah-uddin Ahmed) from the University of Washington.
Group University researchers studied herbal substance epigallocatechin gallate (EGCG), contained in large quantities in green and white tea, and found that it has a pronounced anti-inflammatory properties. The possibility of its use in the treatment of several diseases of inflammatory nature actively studied in recent years, but still clear evidence of its benefits did not exist.
The study found that EGCG is able to inhibit in patients with joint production of cytokines - molecules that stimulate inflammation. Experiments with rats were supplied with artificially induced rheumatoid arthritis. After 10 days, the drug affected joint swelling in an animal decreases markedly.
EGCG may be a promising new tool to combat rheumatoid arthritis, but for its introduction into medical practice is necessary to conduct clinical trials with human participation.
"Existing treatments for rheumatoid arthritis road inhibit operation of the entire immune system and are often unsuitable for long-term use," - said the head of research Sallahuddin Ahmed (Salah-uddin Ahmed) from the University of Washington.
Group University researchers studied herbal substance epigallocatechin gallate (EGCG), contained in large quantities in green and white tea, and found that it has a pronounced anti-inflammatory properties. The possibility of its use in the treatment of several diseases of inflammatory nature actively studied in recent years, but still clear evidence of its benefits did not exist.
The study found that EGCG is able to inhibit in patients with joint production of cytokines - molecules that stimulate inflammation. Experiments with rats were supplied with artificially induced rheumatoid arthritis. After 10 days, the drug affected joint swelling in an animal decreases markedly.
EGCG may be a promising new tool to combat rheumatoid arthritis, but for its introduction into medical practice is necessary to conduct clinical trials with human participation.